Evidence map›Paper›PMID 34926256›Full record

ArticleFrontiers in oncology2021

Classification of MR-Detected Additional Lesions in Patients With Breast Cancer Using a Combination of Radiomics Analysis and Machine Learning.

Hyo-Jae Lee, Anh-Tien Nguyen, So Yeon Ki, Jong Eun Lee, Luu-Ngoc Do, Min Ho Park, Ji Shin Lee, Hye Jung Kim, Ilwoo Park, Hyo Soon Lim

Abstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Machine learning and new insights for breast cancer diagnosis.The Journal of international medical research · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyo-Jae LeeDepartment of Radiology, Chonnam National University Hospital, Gwangju, South Korea.
Anh-Tien NguyenDepartment of Radiology, Chonnam National University Hospital, Gwangju, South Korea.
So Yeon KiDepartment of Radiology, Chonnam National University Hwasun Hospital, Hwasun-gun, South Korea.
Jong Eun LeeDepartment of Radiology, Chonnam National University Hospital, Gwangju, South Korea.
Luu-Ngoc DoDepartment of Radiology, Chonnam National University, Gwangju, South Korea.
Min Ho ParkDepartment of Radiology, Chonnam National University, Gwangju, South Korea.
Ji Shin LeeDepartment of Radiology, Chonnam National University, Gwangju, South Korea.
Hye Jung KimDepartment of Radiology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
Ilwoo ParkDepartment of Radiology, Chonnam National University Hospital, Gwangju, South Korea.
Hyo Soon LimDepartment of Radiology, Chonnam National University Hwasun Hospital, Hwasun-gun, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study was conducted in order to investigate the feasibility of using radiomics analysis (RA) with machine learning algorithms based on breast magnetic resonance (MR) images for discriminating malignant from benign MR-detected additional lesions in patients with primary breast cancer. MATERIALS AND

methodsOne hundred seventy-four MR-detected additional lesions (benign,

resultsThe RA models trained using radiomics features from the intratumor-ROI showed comparable performance to the CII model (accuracy, AUROC: 73.3%, 69.6% for the SUB RA model; 70.0%, 75.1% for the T2 RA model; 73.3%, 72.0% for the CII model). The diagnostic performance increased when the radiomics and CII features were combined to build a fusion model. The fusion model that combines the CII features and radiomics features from multiparametric MRI data demonstrated the highest performance with an accuracy of 86.7% and an AUROC of 91.1%. The external test showed a similar pattern where the fusion models demonstrated higher levels of performance compared with the RA- or CII-only models. The accuracy and AUROC of the SUB+T2 RA+CII model in the external test were 80.6% and 91.4%, respectively.

conclusionOur study demonstrated the feasibility of using RA with machine learning approach based on multiparametric MRI for quantitatively characterizing MR-detected additional lesions. The fusion model demonstrated an improved diagnostic performance over the models trained with either RA or CII alone.

Indexed as

breast neoplasmsmachine learningmagnetic resonance imagingradiomicsultrasonography

Identifiers

PMID34926256
PMCPMC8679659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.